I think this post (https://hotcopper.com.au/posts/73093226/single)
by @mason also applies to Clarity for the following reasons:
- Clarity is in the oncology space which is highly critical, very expensive treatment, and a current hotbed for M&A activity
- Clarity is likely First-in-class (FIC) and Best-in-class (BIC) in TCT’s as both a Dx & Tx especially with >24 hr imaging and 2mm lesion detection (high specificity)
- The trials to date have proven to be highly effective, safe and also requested by EAP for prolonged use
- Bombesin is proving to be a boon to those not expressing PSA and hence a potential niche/ orphan market?
- Sartate etc are cherry on the cake
- My guess is we may enter into breast cancer space shortly with the funding in place.
To top it all, we have a highly capable management who are technically and financially skilled and are just tying the bow on Clarity as the M&A deals are getting closer and there is bound to be news that would be attracting many suitors and this is amply acknowledged by Alan’s comment highlighted above.
AIMO. No advice.
- Forums
- ASX - By Stock
- Ann: Completion of Placement and Institutional Entitlement Offer
I think this post...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.13 |
Change
0.560(10.1%) |
Mkt cap ! $1.910B |
Open | High | Low | Value | Volume |
$5.68 | $6.17 | $5.68 | $13.88M | 2.313M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 210 | $6.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.15 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 210 | 6.080 |
1 | 5833 | 6.070 |
1 | 3000 | 6.050 |
1 | 500 | 6.040 |
1 | 8235 | 6.020 |
Price($) | Vol. | No. |
---|---|---|
6.150 | 2000 | 1 |
6.160 | 925 | 1 |
6.180 | 1000 | 1 |
6.200 | 12280 | 1 |
6.250 | 5233 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |